Nanotech Medical Startup Piscium raises Rs 6 Crore in Series A led by Unicorn India Ventures
Funds raised to be used for strengthening the sales & marketing team, brand building, scale up production & operations and launch international business.
Mumbai-based nanotechnology startup, Piscium, known for its groundbreaking contributions to dental and medical devices, has successfully raised INR 6 crore in a Series A funding round led by Unicorn India Ventures. The funds will be allocated towards reinforcing the sales and marketing team, brand building, scaling up production and operations, and expanding international business initiatives.
Established in 2017 by Malay Dikshit and Dr. Trupta Dikshit, Piscium focuses on dental and medical device manufacturing, aiming to elevate the craft of dental and medical practitioners through innovative research and product development.
The rise in chronic and stress-related diseases, such as diabetes, has heightened the demand for dental care in India. Piscium, with its pioneering research and development in medical sciences, is addressing this demand by manufacturing various dental products, including Alpha Nano Diamond Burs, Epsilon Burs, Alginates, and more.
Piscium's patented Nano Diamond Dental Burs, the first of their kind globally, have gained popularity among dentists for their speed, accuracy, procedural control, and smoothness. Their unique features make specialized designs like fissurotomy and surgical burs particularly beneficial.
The company's portfolio comprises over 10 product categories, featuring a diverse range of dental burs, dental alginates, and other innovative products. Piscium aims to create a comprehensive portfolio of dental and medical devices to empower healthcare professionals and positively impact patients worldwide.
Malay Dikshit, Founder & CEO of Piscium, expressed gratitude for Unicorn India Ventures' support, stating, "By 2027, over 300k dentists across 5 continents would be using Piscium's products as we believe that scientific acumen, a strong innovation pipeline, and an equally strong route to market would be our principal growth drivers."
Since the last funding round, Piscium has strengthened its manufacturing capabilities and vendor ecosystem, expanded its product range, and made significant strides in government procurement. The company has also implemented marketing strategies to enhance its presence in over 10 states.
Anil Joshi, Managing Partner at Unicorn India Ventures, highlighted the escalating prevalence of chronic and stress-related diseases and commended Piscium for its rapid growth driven by innovative products. He emphasized the extensive potential for global market expansion and the substantial growth opportunities that Piscium's future innovations could unlock.
Piscium is actively building its domestic route to market by strengthening its sales force, appointing distributors, and focusing on government procurement. The company has served over 25,000 dentists, and with India's dental care market projected to reach $1.4 billion by 2030, Piscium is poised for hyper-growth in the coming years.
About Piscium: Piscium Health Sciences, based in Mumbai and recognized for its R&D by DSIR, is a dental and medical device company. Incubated by SINE-IITB and supported by BIRAC, Piscium aims to deliver high-quality products that elevate dental and medical practitioners' craft. Promoters are Malay Dikshit & Dr. Trupta Dikshit, with existing investors including E10 Ventures, Zera Ventures, Keiretsu Forum, and HNIs. Website: www.piscium.in
What's Your Reaction?
